These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23317246)

  • 21. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular profiles for insular low-grade gliomas with putamen involvement.
    Zhou C; Wang Y; Liu X; Liang Y; Fan Z; Jiang T; Wang Y; Wang L
    J Neurooncol; 2018 Jul; 138(3):659-666. PubMed ID: 29556911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study.
    Yushan R; Wenjie C; Suning H; Yiwu D; Tengfei Z; Madushi WM; Feifei L; Changwen Z; Xin W; Roodrajeetsing G; Zuyun L; Gang C
    World J Surg Oncol; 2015 Jul; 13():223. PubMed ID: 26205145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The analysis of deregulated expression of the
    Wang F; Chen Q
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S708-S712. PubMed ID: 30249891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of clock gene expression in human colorectal liver metastases.
    Huisman SA; Ahmadi AR; IJzermans JN; Verhoef C; van der Horst GT; de Bruin RW
    Tumour Biol; 2016 Oct; 37(10):13973-13981. PubMed ID: 27492458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.
    Wu X; Wu F; Xu D; Zhang T
    J Neurooncol; 2016 Apr; 127(2):221-32. PubMed ID: 26757925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.
    Xiong J; Zhou L; Yang M; Lim Y; Zhu YH; Fu DL; Li ZW; Zhong JH; Xiao ZC; Zhou XF
    Neuro Oncol; 2013 Aug; 15(8):990-1007. PubMed ID: 23576602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UHRF2 mRNA expression is low in malignant glioma but silencing inhibits the growth of U251 glioma cells in vitro.
    Wu TF; Zhang W; Su ZP; Chen SS; Chen GL; Wei YX; Sun T; Xie XS; Li B; Zhou YX; Du ZW
    Asian Pac J Cancer Prev; 2012; 13(10):5137-42. PubMed ID: 23244124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic value of JAM-A in gliomas.
    Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW
    J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
    Han MZ; Huang B; Chen AJ; Zhang X; Xu R; Wang J; Li XG
    Oncol Rep; 2017 Feb; 37(2):903-912. PubMed ID: 28075478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of clock genes cry1 and cry2 in human colorectal cancer and tumor adjacent tissues correlates differently dependent on tumor location.
    Hasakova K; Vician M; Reis R; Zeman M; Herichova I
    Neoplasma; 2018 Nov; 65(6):986-992. PubMed ID: 29940771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
    Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y
    Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical cholangiocarcinogenesis control by cryptochrome clock genes.
    Mteyrek A; Filipski E; Guettier C; Oklejewicz M; van der Horst GT; Okyar A; Lévi F
    Int J Cancer; 2017 Jun; 140(11):2473-2483. PubMed ID: 28224616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
    Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
    Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression patterns of clock gene mRNAs and clock proteins in human skin tumors.
    Lengyel Z; Lovig C; Kommedal S; Keszthelyi R; Szekeres G; Battyáni Z; Csernus V; Nagy AD
    Tumour Biol; 2013 Apr; 34(2):811-9. PubMed ID: 23242607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas.
    Zeng J; Zhang XK; Chen HD; Zhong ZH; Wu QL; Lin SX
    Oncotarget; 2016 Feb; 7(8):8944-55. PubMed ID: 26771840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and significance of ABCG2 in human malignant glioma].
    Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
    Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.